~~<i id='085345B87F'><strike id='085345B87F'><tt id='085345B87F'><pre id='085345B87F'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

entertainment

author：knowledge 2025-10-01 21:37:33 - browse：11

Roche’s announcement Monday that it would pay $310 million for rights to a hypertension treatment, zilebesiran, invented by the biotech firm Alnylam is evidence of a renewed interest on the part of large pharmaceutical companies for treatments for cardiovascular disease.

If things go well, Roche could pay Alnylam up to $2.8 billion in total.

Heart drugs were once the most lucrative category of pharmaceuticals, but they have been eclipsed by treatments for cancer and other diseases as drug firms have struggled to one-up existing treatments for high blood pressure and high cholesterol that are now available as cheap generics.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： Devoted Health’s losses in Medicare Advantage persist

Wikipedia

explore

hotspot

knowledge

AdobeMyopia,ornear-sightedness,isontherise:Nearlyhalfoftheworld’spopulationwillbenearsightedby2050,

WSS

Top private equity targets in 2023: cardiology, clinical trials, lasers

Unique patient identifier: Experts argue the benefits, pitfalls

Flash flooding emergencies prompt evacuations in Kentucky, Tennessee

Does Medicare's free annual wellness visit do any good?

Gene therapy for Afghan refugees’ infant will be fully covered

Adopting new red light myopia treatments may be short

focus

entertainment

Wikipedia

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Gritstone Bio's cancer vaccine test, and more on Novartis' deal

Dobbs anniversary: the lost opportunity of abortion as health care

Problems with a popular proposal to regulate AI in health care

The high cost of giving birth even with insurance

Vyjuvek, a gene therapy for skin wounds, restored vision in one boy

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

The Biogen Aduhelm mess could happen again

Trump demands the U.S. pay no more for drugs than other countries … again

Jesse Tyler Ferguson makes friendship bracelets for Taylor Swift's Eras Tour

explore

Medical mystery: When an infection after surgery isn’t what it seems

What to know about 'Guardians of the Galaxy Vol. 3' as it hits Disney+

Russian court extends detention of American musician

Climate activists disrupt London Pride march to protest corporate sponsorship

Jailed Russian opposition leader Alexey Navalny gets 19 more years in prison

Climate activists disrupt London Pride march to protest corporate sponsorship

explore

hotspot

hotspot

knowledge